Pembrolizumab for previously treated advanced cervical squamous cell cancer: Preliminary results from the phase 2 KEYNOTE-158 study

被引：53

作者：

Schellens, Jan H. M.

Marabelle, Aurelien

Zeigenfuss, Susan

Ding, Jie

Pruitt, Scott Knowles

Chung, Hyun Cheol

机构：

[1] Netherlands Canc Inst, Amsterdam, Netherlands

[2] Gustave Roussy, Villejuif, France

[3] Merck & Co Inc, Kenilworth, NJ USA

[4] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.5514

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5514

引用

页数：5